TAOX
TAO SynergiesยทNASDAQ
--
--(--)
--
--(--)
TAOX Profile
Tao Synergies Inc.
A company dedicated to the integration of cryptocurrency encryption and artificial intelligence
1185 Avenue of the Americas, 3rd Floor , New York, New York 10036
--
TAO Synergies Inc., was incorporated in Delaware on October 31, 2012. The company is a biopharmaceutical company with product candidates in preclinical and clinical development. The Company is primarily focused on developing a product platform based on a drug candidate called Bryostatin-1, synthesized from a natural product (bryostatin) isolated from marine invertebrate organisms for the treatment of Alzheimer's disease (" AD "), which is in clinical testing.
